Sun Pharma Advanced Research Company Limited accepted the resignation of Mr. Sudhir Valia, as the Chief Financial Officer of the company with effect from end of working hours on January 31, 2017 and appointed Mr. Chetan Rajpara, presently Vice President Treasury of Sun Pharmaceutical Industries Limited, as the Chief Financial Officer of the company with effect from February 1, 2017 in the board of directors meeting held on January 27, 2017. Post his resignation as the Chief Financial Officer of the Company, Mr. Valia will continue to be associated with the Company in his capacity of non-executive director.